债券代码：112468 债券简称：16景峰01 摩根士丹利证券（中国）有限公司 关于 湖南景峰医药股份有限公司 2016 年面向合格投资者公开发行公司债券 （第一期） 受托管理事务临时报告 债券受托管理人 （注册地址：中国（上海）自由贸易试验区世纪大道 100 号上海环球金融中心 75 楼 75T30 室） 2025 年 11 月 1 重要声明 摩根士丹利证券（中国）有限公司（以下简称"摩根士丹利证券"）编制本 报告的内容及信息均来源于湖南景峰医药股份有限公司（以下简称"景峰医药"、 "公司"、"发行人"）对外披露的公告及相关公开信息披露文件。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜作出独立判断，而不应将本报告中的任何内容据以作为摩根士丹利证券所作 的承诺或声明。在任何情况下，未经摩根士丹利证券书面许可，不得用作其他任 何用途，投资者依据本报告所进行的任何作为或不作为，摩根士丹利证券不承担 任何责任。 2 摩根士丹利证券作为湖南景峰医药股份有限公司2016年面向合格投资者公 开发行公司债券（第一期）（以下简称"16景峰01"或"本期债券"）的受托管 理人，持续密切关注对该等债 ...

New Stock Issuance - Multiple new stock issuances are scheduled for November 4, 2025, across various companies, including ST Zhongdi (000609) and Pingtan Development (000592) which reported significant abnormal fluctuations[1] - Jiangbolong (301308) and Xiangnong Xinchuan (300475) are among the companies with recent announcements prior to November 4, 2025[1] Abnormal Fluctuations - Pingtan Development (000592) reported severe abnormal fluctuations on November 4, 2025, indicating potential volatility in its stock performance[1] - Other companies such as ST Panda (600599) and ST Huapeng (603021) also reported abnormal fluctuations on the same date, suggesting a trend of instability in the market[1] Market Trends - The report highlights a growing trend of companies experiencing abnormal stock price movements, which may indicate increased market volatility and investor caution[1] - The presence of multiple companies with abnormal fluctuations could signal a broader market trend that investors should monitor closely[1]

Group 1: New Stock Issuances - Multiple new stock issuances are scheduled for October 31, 2025, including Jiangbolong (301308) and Shikong Technology (605178) [1] - A total of 30 companies have announcements related to stock issuance or trading on this date [1] Group 2: Trading Alerts - Jiangbolong (301308) reported severe abnormal fluctuations in trading [1] - Other companies such as ST Wanfang (000638) and Yashichuangneng (603378) also have trading alerts on the same date [1] Group 3: Recent Announcements - Recent announcements include companies like Tianpu Co. (605255) and Kangsheng Co. (002418) with updates on October 31, 2025 [1] - The announcements cover various sectors, indicating a broad market activity [1]

Group 1: Stock Issuance and Trading Alerts - Multiple stocks experienced significant abnormal fluctuations, including 香农芯创 (300475) and 天普股份 (605255) with announcements on October 24 and 21 respectively[1] - 盈新发展 (000620) and *ST宝鹰 (002047) had announcements on October 30 indicating potential trading alerts[1] - A total of 30 stocks were flagged for abnormal trading activities on October 30, indicating a heightened market volatility[1] Group 2: Recent Announcements - 许多公司如 ST万方 (000638) and 农心科技 (001231) had their announcements published on October 27, indicating ongoing corporate activities[2] - The report includes links to detailed announcements for 30 different stocks, providing transparency and access to information for investors[2] - The announcements cover a range of sectors, highlighting the diverse nature of the market and the potential for investment opportunities[2]

债券代码：112468 债券简称：16景峰01 摩根士丹利证券（中国）有限公司 关于 湖南景峰医药股份有限公司 2016 年面向合格投资者公开发行公司债券 （第一期） 受托管理事务临时报告 债券受托管理人 （注册地址：中国（上海）自由贸易试验区世纪大道 100 号上海环球金融中心 75 楼 75T30 室） 2025 年 10 月 摩根士丹利证券（中国）有限公司（以下简称"摩根士丹利证券"）编制本 报告的内容及信息均来源于湖南景峰医药股份有限公司（以下简称"景峰医药"、 "公司"、"发行人"）对外披露的公告及相关公开信息披露文件。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜作出独立判断，而不应将本报告中的任何内容据以作为摩根士丹利证券所作 的承诺或声明。在任何情况下，未经摩根士丹利证券书面许可，不得用作其他任 何用途，投资者依据本报告所进行的任何作为或不作为，摩根士丹利证券不承担 任何责任。 2 摩根士丹利证券作为湖南景峰医药股份有限公司2016年面向合格投资者公 开发行公司债券（第一期）（以下简称"16景峰01"或"本期债券"）的受托管 理人，持续密切关注对该等债券持有人权益有 ...

债券代码：112468 债券简称：16景峰01 摩根士丹利证券（中国）有限公司 关于湖南景峰医药股份有限公司 2016 年面向合格投资者公开发行公司债券 （第一期） 受托管理事务临时报告 债券受托管理人 景峰医药于2025年10月21日收到湖南省常德市中级人民法院（以下简称"常 德中院"或者"法院"）送达的（2024）湘07破申7号《民事裁定书》和（2025） 湘07破15号《决定书》，裁定受理彭东钜、上海鑫绰投资管理有限公司（以下统 称"申请人"）对公司的重整申请，并指定北京市中伦律师事务所担任公司管理 人。详见公司于同日披露的《关于法院裁定受理公司重整并指定管理人及公司股 票交易将被实施退市风险警示暨公司股票停复牌并变更证券简称的公告》（公告 编号：2025-075）。 （注册地址：中国（上海）自由贸易试验区世纪大道 100 号上海环球金融中心 75 楼 75T30 室） 2025 年 10 月 1 重要声明 摩根士丹利证券（中国）有限公司（以下简称"摩根士丹利证券"）编制本 报告的内容及信息均来源于湖南景峰医药股份有限公司（以下简称"景峰医药"、 "公司"、"发行人"）对外披露的公告及相关公开信息披露文 ...

债券代码：112468 债券简称：16景峰01 摩根士丹利证券（中国）有限公司 关于湖南景峰医药股份有限公司 2016 年面向合格投资者公开发行公司债券 （第一期） 受托管理事务临时报告 债券受托管理人 （注册地址：中国（上海）自由贸易试验区世纪大道 100 号上海环球金融中心 75 楼 75T30 室） 2025 年 10 月 1 重要声明 摩根士丹利证券（中国）有限公司（以下简称"摩根士丹利证券"）编制本 报告的内容及信息均来源于湖南景峰医药股份有限公司（以下简称"景峰医药"、 "公司"、"发行人"）对外披露的公告及相关公开信息披露文件。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜作出独立判断，而不应将本报告中的任何内容据以作为摩根士丹利证券所作 的承诺或声明。在任何情况下，未经摩根士丹利证券书面许可，不得用作其他任 何用途，投资者依据本报告所进行的任何作为或不作为，摩根士丹利证券不承担 任何责任。 2 摩根士丹利证券作为湖南景峰医药股份有限公司2016年面向合格投资者公 开发行公司债券（第一期）（以下简称"16景峰01"或"本期债券"）的受托管 理人，持续密切关注对该等债券 ...

Core Viewpoint - *ST Jingfeng experienced extreme volatility in its stock price, moving from a limit-up to a limit-down situation, indicating significant market fluctuations and investor sentiment shifts [2] Trading Performance - The stock recorded a trading volume of 50.68 million shares and a transaction value of 406 million yuan, reflecting high trading activity [2] - The stock exhibited a price fluctuation of 9.91% and a turnover rate of 5.76%, indicating substantial investor interest and volatility [2] - The amount of sell orders at the limit-down price reached 2.96 million yuan, suggesting strong selling pressure [2]

Core Viewpoint - *ST Jingfeng (000908.SZ) reported its Q3 2025 results, highlighting the presence of institutional investors holding a significant stake in the company [1] Group 1: Institutional Holdings - As of October 28, 2025, there are 2 institutional investors disclosing their holdings in *ST Jingfeng A-shares, totaling 125 million shares [1] - The total shares held by institutional investors account for 14.18% of *ST Jingfeng's total share capital [1] - The institutional investors include China Great Wall Asset Management Co., Ltd. and Pingjiang County State-owned Assets Administration Center, with the combined holding percentage remaining unchanged [1]

Market Overview - Major market indices opened higher, with the Shanghai Composite Index rising by 0.05% to 3990.27 points, the Shenzhen Component Index increasing by 0.40% to 13484.01 points, and the ChiNext Index up by 1.07% to 3263.98 points [1] Stock Performance - A total of 1761 stocks rose at the opening, with 11 stocks hitting the daily limit up. Notable performers included *ST Wanfang with 11 consecutive limit ups over 13 days, ST Zhongdi with 9 consecutive limit ups, and Pingtan Development with 7 limit ups over 9 days [1] - Conversely, 2802 stocks declined at the opening, with 6 stocks hitting the daily limit down, including *ST Suwu and *ST Heke [1] Price Continuity - Among stocks that hit the limit up yesterday, 9 stocks continued to rise at the opening today, including Pingtan Development and Shikong Technology. Stocks that opened lower included Yashi Chuangneng, Geer Software, and *ST Nanzhi, with declines of 5.20%, 5.04%, and 4.83% respectively [1] - From the stocks that hit the limit down yesterday, 4 stocks continued to decline today, including *ST Suwu and *ST Heke [1]